Earnings Feed
Start Free
Home/Filings/4/0001123292-07-000544
4//SEC Filing

CONNOR EDWARD M 4

Accession 0001123292-07-000544

CIK 0000873591other
View on SEC.govCompany Profile

Filed

Jun 18, 8:00 PM ET

Accepted

Jun 19, 5:27 PM ET

Size

32.5 KB

Accession

0001123292-07-000544

Insider Transaction Report

Form 4
Period: 2007-06-18
MEDIMMUNE INC /DEMEDI
CONNOR EDWARD M
EVP and Chief Medical Officer
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-18−10,000→ 0 total
    Exercise: $36.92Exp: 2011-05-11→ Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-18−90,000→ 0 total
    Exercise: $29.34Exp: 2013-02-20→ Common Stock (90,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-18−75,000→ 0 total
    Exercise: $41.41Exp: 2012-02-21→ Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-18−25,000→ 0 total
    Exercise: $23.13Exp: 2014-08-24→ Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-18−15,000→ 0 total
    Exercise: $25.40Exp: 2012-07-19→ Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-18−45,000→ 0 total
    Exercise: $18.91Exp: 2009-02-24→ Common Stock (45,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-18−100,000→ 0 total
    Exercise: $24.17Exp: 2015-02-15→ Common Stock (100,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-18−40,000→ 0 total
    Exercise: $38.69Exp: 2011-02-15→ Common Stock (40,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-18−60,000→ 0 total
    Exercise: $8.29Exp: 2008-02-25→ Common Stock (60,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-18−80,000→ 0 total
    Exercise: $31.25Exp: 2017-02-14→ Common Stock (80,000 underlying)
Footnotes (12)
  • [F1]This option, which provided for vesting in four equal annual installments beginning on 2/25/1999, was cancelled pursuant to the merger agreement between the issuer and AstraZeneca PLC in exchange for a cash payment of $49.71 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F10]This option, which provided for vesting in equal quarterly installments beginning 05/16/2005, was cancelled in the merger in exchange for a cash payment of $33.83 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F11]This option, which provided for vesting in equal quarterly installments beginning 05/23/2006, was cancelled in the merger in exchange for a cash payment of $21.22 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F12]This option, which provided for vesting in equal quarterly installments beginning 5/15/2008, was cancelled in the merger in exchange for a cash payment of $26.75 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F2]This option, which provided for vesting in four equal annual installments beginning on 2/24/2000, was cancelled in the merger in exchange for a cash payment of $39.09 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F3]This option, which provided for vesting in equal quarterly installments beginning 5/15/2001, was cancelled in the merger in exchange for a cash payment of $19.31 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F4]This option, which provided for vesting in equal quarterly installments beginning 8/11/2001, was cancelled in the merger in exchange for a cash payment of $21.08 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F5]This option, which provided for vesting in equal quarterly installments beginning 05/21/2002, was cancelled in the merger in exchange for a cash payment of $16.59 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F6]This option, which provided for vesting in equal quarterly installments beginning 10/19/2002, was cancelled in the merger in exchange for a cash payment of $32.60 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F7]This option, which provided for vesting in equal quarterly installments beginning 5/20/2003, was cancelled in the merger in exchange for a cash payment of $28.66 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F8]This option, which provided for vesting in equal quarterly installments beginning 6/4/2004, was cancelled in the merger in exchange for a cash payment of $34.55 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F9]This option, which provided for vesting in equal quarterly installments beginning 11/25/2004, was cancelled in the merger in exchange for a cash payment of $34.87 per share, representing the difference between the exercise price of the option and $58.00 per share.

Documents

1 file

Issuer

MEDIMMUNE INC /DE

CIK 0000873591

→
Entity typeother

Related Parties

1
  • filerCIK 0001228182

Filing Metadata

Form type
4
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:27 PM ET
Size
32.5 KB
View on SEC.gov